Black Diamond Therapeutics Stock Performance
| BDTX Stock | USD 5.02 0.24 4.56% |
Black Diamond holds a performance score of 13 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 1.77, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Black Diamond will likely underperform. Use Black Diamond value at risk, and the relationship between the standard deviation and kurtosis , to analyze future returns on Black Diamond.
Risk-Adjusted Performance
13 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Black Diamond Therapeutics are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Black Diamond showed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 1.99 | Five Day Return (10.49) | Year To Date Return 75.95 | Ten Year Return (87.03) | All Time Return (87.03) |
1 | Were Keeping An Eye On Black Diamond Therapeutics Cash Burn Rate | 01/31/2024 |
2 | Black Diamond Therapeutics, Inc. Sees Large Decline in Short Interest - MarketBeat | 02/12/2024 |
3 | Acquisition by Yurasov Sergey of 225000 shares of Black Diamond subject to Rule 16b-3 | 02/15/2024 |
4 | Barclays PLC Acquires 197895 Shares of Black Diamond Therapeutics, Inc. - MarketBeat | 02/21/2024 |
5 | Black Diamond Therapeutics Announces Upcoming Presentation at AACR Annual Meeting 2024 | 03/05/2024 |
6 | Black Diamond Therapeutics Inc Reports Q4 and Full Year 2023 Financials, Advances ... | 03/14/2024 |
7 | Black Diamond Therapeutics Rating Reiterated by HC Wainwright - Defense World | 03/19/2024 |
8 | Black Diamond Therapeutics Options Chain Prices 2024 - MarketBeat | 03/25/2024 |
9 | Black Diamond Therapeutics to Present at Upcoming Investor Conferences - The Globe and Mail | 04/04/2024 |
10 | Insider Trading | 04/10/2024 |
11 | Black Diamond Upgraded to Buy What Does It Mean for the Stock | 04/15/2024 |
| Begin Period Cash Flow | 34.3 M |
Black |
Black Diamond Relative Risk vs. Return Landscape
If you would invest 280.00 in Black Diamond Therapeutics on January 24, 2024 and sell it today you would earn a total of 222.00 from holding Black Diamond Therapeutics or generate 79.29% return on investment over 90 days. Black Diamond Therapeutics is currently generating 1.1472% in daily expected returns and assumes 6.5107% risk (volatility on return distribution) over the 90 days horizon. In different words, 57% of stocks are less volatile than Black, and 78% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Black Diamond Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Black Diamond's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Black Diamond Therapeutics, and traders can use it to determine the average amount a Black Diamond's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1762
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BDTX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.51 actual daily | 57 57% of assets are less volatile |
Expected Return
| 1.15 actual daily | 22 78% of assets have higher returns |
Risk-Adjusted Return
| 0.18 actual daily | 13 87% of assets perform better |
Based on monthly moving average Black Diamond is performing at about 13% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Black Diamond by adding it to a well-diversified portfolio.
Black Diamond Fundamentals Growth
Black Stock prices reflect investors' perceptions of the future prospects and financial health of Black Diamond, and Black Diamond fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Black Stock performance.
| Return On Equity | -0.71 | ||||
| Return On Asset | -0.34 | ||||
| Current Valuation | 153.52 M | ||||
| Shares Outstanding | 51.72 M | ||||
| Price To Book | 2.32 X | ||||
| EBITDA | (86.02 M) | ||||
| Net Income | (82.44 M) | ||||
| Cash And Equivalents | 160.89 M | ||||
| Cash Per Share | 4.43 X | ||||
| Total Debt | 25.3 M | ||||
| Debt To Equity | 0.19 % | ||||
| Current Ratio | 8.55 X | ||||
| Book Value Per Share | 2.26 X | ||||
| Cash Flow From Operations | (66.72 M) | ||||
| Earnings Per Share | (1.88) X | ||||
| Market Capitalization | 259.62 M | ||||
| Total Asset | 158.57 M | ||||
| Retained Earnings | (417.43 M) | ||||
| Working Capital | 114.39 M | ||||
| Current Asset | 123.51 M | ||||
| Current Liabilities | 4.43 M | ||||
About Black Diamond Performance
To evaluate Black Diamond Therap Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Black Diamond generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Black Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Black Diamond Therap market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Black's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 0.00 | 0.00 | |
| Return On Tangible Assets | (0.52) | (0.55) | |
| Return On Capital Employed | (0.62) | (0.65) | |
| Return On Assets | (0.52) | (0.55) | |
| Return On Equity | (0.71) | (0.67) |
Things to note about Black Diamond Therap performance evaluation
Checking the ongoing alerts about Black Diamond for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Black Diamond Therap help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Black Diamond Therap is way too risky over 90 days horizon | |
| Black Diamond Therap appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (82.44 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Black Diamond Therapeutics currently holds about 160.89 M in cash with (66.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.43. | |
| Black Diamond Therap has a frail financial position based on the latest SEC disclosures | |
| Over 94.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from zacks.com: Black Diamond Upgraded to Buy What Does It Mean for the Stock |
- Analyzing Black Diamond's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Black Diamond's stock is overvalued or undervalued compared to its peers.
- Examining Black Diamond's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Black Diamond's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Black Diamond's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Black Diamond's stock. These opinions can provide insight into Black Diamond's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Black Diamond Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Complementary Tools for Black Stock analysis
When running Black Diamond's price analysis, check to measure Black Diamond's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Black Diamond is operating at the current time. Most of Black Diamond's value examination focuses on studying past and present price action to predict the probability of Black Diamond's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Black Diamond's price. Additionally, you may evaluate how the addition of Black Diamond to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |
Is Black Diamond's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Black Diamond. If investors know Black will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Black Diamond listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.88) | Return On Assets (0.34) | Return On Equity (0.71) |
The market value of Black Diamond Therap is measured differently than its book value, which is the value of Black that is recorded on the company's balance sheet. Investors also form their own opinion of Black Diamond's value that differs from its market value or its book value, called intrinsic value, which is Black Diamond's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Black Diamond's market value can be influenced by many factors that don't directly affect Black Diamond's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Black Diamond's value and its price as these two are different measures arrived at by different means. Investors typically determine if Black Diamond is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Black Diamond's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.